Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma
Abroad (travel likely)RecruitingPHASE2
Conditions
Mestastatic Uveal Melanoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Charité - Universitätsmedizin Berlin, Berlin, State of Berlin, Germany
Contact: Study coordinator (A responsible person Selected by Sponsor,, M.D., Ph.D.) · investigacion@mfar.net · +34 93 434 44 12Institut Catala d'Oncologia (ICO) Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain
Contact: Study coordinator (Principal Investigator Selected by Sponsor,, M.D., Ph.D.) · investigacion@mfar.net · +34 93 434 44 12Hospital La Paz, Madrid, Madrid, Spain
Contact: Study coordinator (A responsible person Selected by Sponsor,, M.D., Ph.D.) · investigacion@mfar.net · +34 93 434 44 12Consorcio Hospital General Universitario de Valencia, Valencia, Valencia, Spain
Contact: Study coordinator (A responsible person Selected by Sponsor,, M.D., Ph.D.) · investigacion@mfar.net · +34 93 434 44 12
Study leads
Josep Maria Piulats, M.D., Ph.D.
Study Chair
Institut Catala d'Oncologia (ICO) Hospitalet